Visit | AyuFlex1 (n = 37) | AyuFlex2 (n = 39) | Placebo (n = 34) | p value | ||||
---|---|---|---|---|---|---|---|---|
Overalla | AF1 + AF2 vs PBO | AF1 vs PBO | AF2 vs PBO | AF1 vs AF2 | ||||
Overalla | 0.085 | 0.044 | 0.054 | 0.082 | 0.361 | |||
0 | 43.8 (±22.8) | 52.0 (±25.7) | 40.5 (±20.8) | |||||
14 | 39.1 (±23.5) | 41.7 (±22.8) | 40.7 (±20.2) | 0.122 | 0.266 | 0.090 | 0.536 | |
42 | 32.2 (±22.5) | 39.4 (±22.9) | 39.8 (±22.9) | 0.097 | 0.050 | 0.430 | 0.414 | |
84 | 25.7 (±19.0) | 30.3 (±21.6) | 40.9 (±24.1) | 0.001 | 0.001 | 0.008 | 0.595 | |
Changes to Measures of Discomfort with Activity or Exerciseb | ||||||||
−18.2 (±23.5) | −21.7 (±28.6) | 0.4 (±24.1) | 0.001 | <0.001 | 0.002 | <0.001 | 0.547 |